Skip to main content
Top
Published in: BMC Nephrology 1/2017

Open Access 01-12-2017 | Case report

IgA nephropathy featuring massive wire loop-like deposits in two patients with alcoholic cirrhosis

Authors: Daisuke Takada, Keiichi Sumida, Akinari Sekine, Ryo Hazue, Masayuki Yamanouchi, Tatsuya Suwabe, Noriko Hayami, Junichi Hoshino, Naoki Sawa, Kenmei Takaichi, Takeshi Fujii, Kenichi Ohashi, Yoshifumi Ubara

Published in: BMC Nephrology | Issue 1/2017

Login to get access

Abstract

Background

Various renal manifestations are known to develop in patients with liver disease, including chronic hepatitis and cirrhosis.

Case presentation

We evaluated renal disease in two 47-year-old Japanese men with liver cirrhosis and chronic alcoholism for 34 years and 27 years, respectively. Renal biopsy demonstrated massive wire loop-like deposits in the subendothelial space of the glomerular basement membrane and in the mesangium. However, immunofluorescence was only positive for IgA and C3, and electron microscopy did not reveal any organized structures in the electron-dense deposits. IgA nephropathy was diagnosed, although the features were different from primary IgA nephropathy. Both patients had portosystemic shunts associated with liver cirrhosis. Their renal deposits and proteinuria resolved completely after 1 year of steroid therapy.

Conclusion

Alcohol abuse may have contributed to development of secondary IgA nephropathy in these two patients, probably via their portosystemic shunts.
Literature
1.
go back to reference Sumida K, Ubara Y, Hoshino J, Suwabe T, Nakanishi S, Hiramatsu R, Hasegawa E, Hayami N, Yamanouchi M, Sawa N, Takemoto F, Takaichi K, Oohashi K. Hepatitis C virus-related kidney disease: various histological patterns. Clin Nephrol. 2010;74(6):446–56.PubMed Sumida K, Ubara Y, Hoshino J, Suwabe T, Nakanishi S, Hiramatsu R, Hasegawa E, Hayami N, Yamanouchi M, Sawa N, Takemoto F, Takaichi K, Oohashi K. Hepatitis C virus-related kidney disease: various histological patterns. Clin Nephrol. 2010;74(6):446–56.PubMed
2.
go back to reference Hiramatsu R, Hoshino J, Suwabe T, Sumida K, Hasegawa E, Yamanouchi M, Hayami N, Sawa N, Takaichi K, Ohashi K, Fujii T, Ubara Y. Membranoproliferative glomerulonephritis and circulating cryoglobulins. Clin Exp Nephrol. 2014;18(1):88–94.CrossRefPubMed Hiramatsu R, Hoshino J, Suwabe T, Sumida K, Hasegawa E, Yamanouchi M, Hayami N, Sawa N, Takaichi K, Ohashi K, Fujii T, Ubara Y. Membranoproliferative glomerulonephritis and circulating cryoglobulins. Clin Exp Nephrol. 2014;18(1):88–94.CrossRefPubMed
3.
go back to reference Zhou XJ, Silva FG. Membranoproliferative glomerulonephritis. In: Jennette JC, Olson JL, Silva FG, D’Agati VD, editors. Heptinstall’s pathology of the kidney. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 328–31. Zhou XJ, Silva FG. Membranoproliferative glomerulonephritis. In: Jennette JC, Olson JL, Silva FG, D’Agati VD, editors. Heptinstall’s pathology of the kidney. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 328–31.
4.
go back to reference Smith SM, Yu GS, Tsukamoto H. IgA nephropathy in alcohol abuse. An animal model. Lab Investig. 1990;62(2):179–84.PubMed Smith SM, Yu GS, Tsukamoto H. IgA nephropathy in alcohol abuse. An animal model. Lab Investig. 1990;62(2):179–84.PubMed
5.
go back to reference Haas M. IgA nephropthy and IgA vasculitis. In: Jennette JC, Olson JL, Silva FG, D’Agati VD, editors. Heptinstall’s pathology of the kidney. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 496–9. Haas M. IgA nephropthy and IgA vasculitis. In: Jennette JC, Olson JL, Silva FG, D’Agati VD, editors. Heptinstall’s pathology of the kidney. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 496–9.
6.
go back to reference Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59(1):160–8.CrossRefPubMed Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59(1):160–8.CrossRefPubMed
8.
go back to reference Endo Y, Matsushita H, Nozawa Y, Nishikage S, Matsuya S, Hara M. Glomerulonephritis associated with liver cirrhosis. Acta Pathol Jpn. 1983;33(2):333–46.PubMed Endo Y, Matsushita H, Nozawa Y, Nishikage S, Matsuya S, Hara M. Glomerulonephritis associated with liver cirrhosis. Acta Pathol Jpn. 1983;33(2):333–46.PubMed
9.
go back to reference Kaartinen K, Niemela O, Syrjanen J, Porsti I, Harmoinen A, Pasternack A, Huhtala H, Mustonen J. Alcohol consumption and kidney function in IgA glomerulonephritis. Nephron Clin Pract. 2009;112(2):c86–93.CrossRefPubMed Kaartinen K, Niemela O, Syrjanen J, Porsti I, Harmoinen A, Pasternack A, Huhtala H, Mustonen J. Alcohol consumption and kidney function in IgA glomerulonephritis. Nephron Clin Pract. 2009;112(2):c86–93.CrossRefPubMed
10.
go back to reference Koning SH, Gansevoort RT, Mukamal KJ, Rimm EB, Bakker SJ, Joosten MM. PREVEND study group alcohol consumption is inversely associated with the risk of developing chronic kidney disease. Kidney Int. 2015;87(5):1009–16.CrossRefPubMed Koning SH, Gansevoort RT, Mukamal KJ, Rimm EB, Bakker SJ, Joosten MM. PREVEND study group alcohol consumption is inversely associated with the risk of developing chronic kidney disease. Kidney Int. 2015;87(5):1009–16.CrossRefPubMed
11.
go back to reference Newell GC. Cirrhotic glomerulonephritis: incidence, morphology, clinical features, and pathogenesis. Am J Kidney Dis. 1987;9(3):183–90.CrossRefPubMed Newell GC. Cirrhotic glomerulonephritis: incidence, morphology, clinical features, and pathogenesis. Am J Kidney Dis. 1987;9(3):183–90.CrossRefPubMed
12.
go back to reference Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. Kidney Int. 2011;80(12):1352–63.CrossRefPubMed Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. Kidney Int. 2011;80(12):1352–63.CrossRefPubMed
15.
go back to reference Dash SC, Bhuyan UN, Dinda AK, Saxena S, Agarwal SK, Tiwari SC, Nundy S. Increased incidence of glomerulonephritis following spleno-renal shunt surgery in non-cirrhotic portal fibrosis. Kidney Int. 1997;52(2):482–5.CrossRefPubMed Dash SC, Bhuyan UN, Dinda AK, Saxena S, Agarwal SK, Tiwari SC, Nundy S. Increased incidence of glomerulonephritis following spleno-renal shunt surgery in non-cirrhotic portal fibrosis. Kidney Int. 1997;52(2):482–5.CrossRefPubMed
16.
go back to reference Soma J, Saito T, Sato H, Ootaka T, Abe K. Membranoproliferative glomerulonephritis induced by portosystemic shunt surgery for non-cirrhotic portal hypertension. Clin Nephrol. 1997;48(5):274–81.PubMed Soma J, Saito T, Sato H, Ootaka T, Abe K. Membranoproliferative glomerulonephritis induced by portosystemic shunt surgery for non-cirrhotic portal hypertension. Clin Nephrol. 1997;48(5):274–81.PubMed
Metadata
Title
IgA nephropathy featuring massive wire loop-like deposits in two patients with alcoholic cirrhosis
Authors
Daisuke Takada
Keiichi Sumida
Akinari Sekine
Ryo Hazue
Masayuki Yamanouchi
Tatsuya Suwabe
Noriko Hayami
Junichi Hoshino
Naoki Sawa
Kenmei Takaichi
Takeshi Fujii
Kenichi Ohashi
Yoshifumi Ubara
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2017
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-017-0769-1

Other articles of this Issue 1/2017

BMC Nephrology 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.